{"id":"ketamine-plus-usual-care","safety":{"commonSideEffects":[{"rate":null,"effect":"Dissociation"},{"rate":null,"effect":"Increased heart rate"},{"rate":null,"effect":"Increased blood pressure"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Nausea"}]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Ketamine plus usual care","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:53:26.483779+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T04:53:41.291673+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:53:33.317590+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ketamine plus usual care","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:53:34.060570+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL742/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:53:34.755476+00:00"}},"_dailymed":null,"aiSummary":"Ketamine plus usual care, marketed by The University of Texas Health Science Center, Houston, is a treatment currently available in the market. A key strength is the protection provided by the key composition patent, which expires in 2028. The primary risk is the lack of detailed revenue data and key trial results, which may limit strategic planning and investor confidence.","mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ketamine is a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor, a subtype of glutamate receptor. This blockade interrupts pain signal transmission and produces dissociative anesthesia. When combined with usual care, ketamine may provide enhanced analgesia and sedation in acute or perioperative settings.","oneSentence":"Ketamine blocks NMDA glutamate receptors in the brain, producing rapid-onset dissociative anesthesia and analgesic effects.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:33:42.664Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T04:53:41.292094+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Anesthesia induction and maintenance (in combination with standard care)"},{"name":"Acute pain management (in combination with standard care)"}]},"trialDetails":[{"nctId":"NCT05446623","phase":"PHASE2, PHASE3","title":"Cardiac Index and General Anesthesia Without Opioid.","status":"COMPLETED","sponsor":"Centre Hospitalier de Montauban","startDate":"2021-01-01","conditions":"Hip Arthropathy, Hip Disease","enrollment":120},{"nctId":"NCT06419439","phase":"PHASE2","title":"Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-12-03","conditions":"Chronic Low Back Pain, Depression","enrollment":44},{"nctId":"NCT06431386","phase":"NA","title":"Behavioural Activation Therapy and Esketamine for Resistant Depression","status":"TERMINATED","sponsor":"The Royal's Institute of Mental Health Research","startDate":"2024-06-11","conditions":"Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major, Bipolar Disorder","enrollment":6},{"nctId":"NCT06788444","phase":"NA","title":"Efficacy of Esketamine for Patients With Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-18","conditions":"Irritable Bowel Syndrome","enrollment":552},{"nctId":"NCT07120477","phase":"PHASE4","title":"Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian Cities","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2026-01","conditions":"Suicide Prevention, Ketamine, Crisis Response Plan","enrollment":500},{"nctId":"NCT05577585","phase":"NA","title":"Ketamine in OCD: Efficacy and Effects on Stress and Cognition","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2022-10-01","conditions":"Obsessive-Compulsive Disorder, Psychiatric Disorder","enrollment":60},{"nctId":"NCT05825560","phase":"PHASE4","title":"Opioid-free Analgesia in Intensive Care Unit","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-05-15","conditions":"Intubation","enrollment":50},{"nctId":"NCT05696691","phase":"PHASE2, PHASE3","title":"Ketamine & Crisis Response Plan for Suicidal Ideation in the ED","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2023-01-06","conditions":"Suicide","enrollment":24},{"nctId":"NCT05345639","phase":"PHASE3","title":"Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study)","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2022-08-01","conditions":"Pain, Postoperative, Cardiac Surgery","enrollment":254},{"nctId":"NCT01900847","phase":"NA","title":"Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency Department","status":"TERMINATED","sponsor":"University of Arizona","startDate":"2013-06-01","conditions":"Acute Pain","enrollment":17},{"nctId":"NCT04129086","phase":"PHASE4","title":"Ketamine for Acute Pain Management After Trauma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-07-01","conditions":"Trauma Injury, Pain, Opioid Use","enrollment":305},{"nctId":"NCT04701866","phase":"NA","title":"Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression","status":"COMPLETED","sponsor":"Douglas Mental Health University Institute","startDate":"2021-01-11","conditions":"Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major, Unipolar Depression","enrollment":32},{"nctId":"NCT04005209","phase":"PHASE4","title":"Ketamine Infusion for Sickle Cell Pain Crisis","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2022-01","conditions":"Anemia; Sickle-Cell, With Crisis, Acute Pain","enrollment":""},{"nctId":"NCT04658420","phase":"PHASE2","title":"A Single Ketamine Infusion Combined With Music for Suicidal Ideation","status":"UNKNOWN","sponsor":"The University of Texas Health Science Center at Tyler","startDate":"2021-07-01","conditions":"Suicidal Ideation, Depressive Episode","enrollment":200},{"nctId":"NCT03448068","phase":"PHASE2","title":"Perioperative Ketamine for Pain With Gastric Bypass","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-04-16","conditions":"Laparoscopic Gastric Bypass Surgery, Ketamine","enrollment":34},{"nctId":"NCT03305055","phase":"PHASE4","title":"RCT: Fentanyl Plus Ketamine Versus Fentanyl Alone for Acute Burn Pain","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2017-12-16","conditions":"Acute Pain, Wound Care, Posttraumatic Stress Disorder","enrollment":4},{"nctId":"NCT02593643","phase":"EARLY_PHASE1","title":"Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2016-01","conditions":"Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder","enrollment":9}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL742"},"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ketamine plus usual care","genericName":"Ketamine plus usual care","companyName":"The University of Texas Health Science Center, Houston","companyId":"the-university-of-texas-health-science-center-houston","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T04:53:41.292094+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}